Abstract
Five decades of extensive research have passed since the description for the first time of the existence of an enzyme, which had the ability to degrade collagen during the metamorphosis of tadpoles. In fact, during these years, a large family of enzymes possessing the unique ability of degrading the extra cellular matrix (ECM) has been discovered. These enzymes are widely known as Matrix Metalloproteinases (MMPs) and it is noteworthy that many members of this family are directly linked to several human diseases such as arthritis and cancer. Moreover, due to the critical role of certain members of MMPs in cancer invasion and metastasis, great efforts have been made in order to find new inhibitory compounds against these MMPs. In this work we attempt to summarize the current status of the intervention strategies against MMPs, using inhibitory compounds that could block the activation of MMPs directly or indirectly. Furthermore we will try to shed light towards new potential strategies of MMP inhibitors using monoclonal antibodies.
Keywords: Matrix metalloproteinases, Cancer, Monoclonal antibodies, Inhibitors, tissue inhibitors of matrix metalloproteinases, hemopexin-like, propeptide, glycosylphosphatidylinositol, melanoma cell, angiogenesis.
Anti-Cancer Agents in Medicinal Chemistry
Title:Inhibiting Matrix Metalloproteinases, an Old Story with New Potentials for Cancer Treatment
Volume: 12 Issue: 7
Author(s): Dimitris Stellas and Evangelia Patsavoudi
Affiliation:
Keywords: Matrix metalloproteinases, Cancer, Monoclonal antibodies, Inhibitors, tissue inhibitors of matrix metalloproteinases, hemopexin-like, propeptide, glycosylphosphatidylinositol, melanoma cell, angiogenesis.
Abstract: Five decades of extensive research have passed since the description for the first time of the existence of an enzyme, which had the ability to degrade collagen during the metamorphosis of tadpoles. In fact, during these years, a large family of enzymes possessing the unique ability of degrading the extra cellular matrix (ECM) has been discovered. These enzymes are widely known as Matrix Metalloproteinases (MMPs) and it is noteworthy that many members of this family are directly linked to several human diseases such as arthritis and cancer. Moreover, due to the critical role of certain members of MMPs in cancer invasion and metastasis, great efforts have been made in order to find new inhibitory compounds against these MMPs. In this work we attempt to summarize the current status of the intervention strategies against MMPs, using inhibitory compounds that could block the activation of MMPs directly or indirectly. Furthermore we will try to shed light towards new potential strategies of MMP inhibitors using monoclonal antibodies.
Export Options
About this article
Cite this article as:
Stellas Dimitris and Patsavoudi Evangelia, Inhibiting Matrix Metalloproteinases, an Old Story with New Potentials for Cancer Treatment, Anti-Cancer Agents in Medicinal Chemistry 2012; 12 (7) . https://dx.doi.org/10.2174/187152012802650246
DOI https://dx.doi.org/10.2174/187152012802650246 |
Print ISSN 1871-5206 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5992 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Recent Advances in the Study of Glycosphingolipids
Current Pharmaceutical Biotechnology Diet-Derived Phytochemicals: From Cancer Chemoprevention to Cardio-Oncological Prevention
Current Drug Targets Role of Chemokines and Their Receptors in Cancer
Current Pharmaceutical Design MtDNA As a Cancer Marker: A Finally Closed Chapter?
Current Genomics Sphere Formation Assay is not an Effective Method for Cancer Stem Cell Derivation and Characterization from the Caco-2 Colorectal Cell Line
Current Stem Cell Research & Therapy Calcium as a Molecular Target in Angiogenesis
Current Pharmaceutical Design Radiolabelled Peptides: Eon in Radiopharmaceutical
Current Radiopharmaceuticals Differentiation Between Osteoporotic and Neoplastic Vertebral Fractures: State of The Art and Future Perspectives
Current Medical Imaging Intestinal Targeting of Drugs: Rational Design Approaches and Challenges
Current Topics in Medicinal Chemistry Inflammasomes – A Mini-Review
Current Immunology Reviews (Discontinued) Anticancer Potential of Mefenamic Acid Derivatives with Platelet-Derived Growth Factor Inhibitory Property
Anti-Cancer Agents in Medicinal Chemistry Enhancing Transdermal Drug Delivery with Electroporation
Recent Patents on Drug Delivery & Formulation Recent Advances in Liver X Receptor Biology and Chemistry
Current Topics in Medicinal Chemistry Has Selenium a Chemopreventive Effect on Hepatocellular Carcinoma?
Mini-Reviews in Medicinal Chemistry Supplementation with Curcuma longa Reverses Neurotoxic and Behavioral Damage in Models of Alzheimer’s Disease: A Systematic Review
Current Neuropharmacology Computational Approaches for the Identification and Optimization of Src Family Kinases Inhibitors
Current Medicinal Chemistry Molecular Mechanisms of Thymoquinone as Anticancer Agent
Combinatorial Chemistry & High Throughput Screening Pentapeptides as Minimal Functional Units in Cell Biology and Immunology
Current Protein & Peptide Science Honey as a Source of Dietary Antioxidants: Structures, Bioavailability and Evidence of Protective Effects Against Human Chronic Diseases
Current Medicinal Chemistry Role of Apoptosis and Proinflammatory Cytokines in Influenza Virus Morbidity and Mortality
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry